Cardiomyocyte-specific CYP2J2 and its therapeutic implications
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - September 9, 2022 Category: Drugs & Pharmacology Authors: Robert Valencia Wesam Bassiouni Ahmed M. Darwesh Raj Bapuji John M. Seubert Source Type: research

Important roles of transporters in the pharmacokinetics of anti-viral nucleoside/nucleotide analogs
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - September 9, 2022 Category: Drugs & Pharmacology Authors: Mengbi Yang Xin Xu Source Type: research

The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - September 5, 2022 Category: Drugs & Pharmacology Authors: Birgit C.P. Koch Qiaolin Zhao Maartje Oosterhoff Jakob van Oldenrijk Alan Abdulla Brenda C.M. de Winter Koen Bos Anouk E. Muller Source Type: research

Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care – an overview
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 30, 2022 Category: Drugs & Pharmacology Authors: Gianluca D ’Onofrio Antonella Riva Elisabetta Amadori Simona Lattanzi Klaus Rose Alberto Verrotti Pasquale Striano Source Type: research

The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 30, 2022 Category: Drugs & Pharmacology Authors: Nadeen Anabtawi Thomas Drabison Shuiying Hu Alex Sparreboom Zahra Talebi Source Type: research

Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 25, 2022 Category: Drugs & Pharmacology Authors: Robert A. Roth Omar Kana David Filipovic Patricia E. Ganey Source Type: research

Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 23, 2022 Category: Drugs & Pharmacology Authors: Giulio Evangelisti Fabio Barra Umberto Perrone Nadine Di Donato Stefano Bogliolo Marcello Ceccaroni Simone Ferrero Source Type: research

Comorbidities and the right dose: antipsychotics
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 23, 2022 Category: Drugs & Pharmacology Authors: Nicolas Simon Romain Torrents Jean-Michel Azorin Source Type: research

A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 18, 2022 Category: Drugs & Pharmacology Authors: Zhengzhi Liu Zhenyue Gao Wei Yang Lixiu Zhang Nan Xiao Dongmei Qu Zhengjie Su Kaibo Xu Guangwen Liu Yanli Wang Qing Ren Shuang Yu Yang Cheng Yannan Zhou Qiaohuan Deng Yicheng Zhao Zeyu Wang Haimiao Yang Source Type: research

Cytochrome P450 oxidoreductase variant A503V contributes to the increased CYP3A5 activity with tacrolimus in vitro
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 17, 2022 Category: Drugs & Pharmacology Authors: Yuan Gao Jingjing Ma Source Type: research

Drug-drug interactions between psychotropic medications and oral contraceptives
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 5, 2022 Category: Drugs & Pharmacology Authors: Georgios Schoretsanitis Kristina M. Deligiannidis Michael Paulzen Edoardo Spina Jose de Leon Source Type: research

The impact of sepsis on hepatic drug metabolism in critically ill patients: a narrative review
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 3, 2022 Category: Drugs & Pharmacology Authors: Tim MJ Ewoldt Alan Abdulla Nicole Hunfeld Letao Li Tim J.L. Smeets Diederik Gommers Birgit C.P. Koch Henrik Endeman Source Type: research

Counteracting heart failure with diabetes drugs: a review into the pharmacokinetic and pharmacodynamic properties
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 2, 2022 Category: Drugs & Pharmacology Authors: Andr é J. Scheen Source Type: research

Strategies for the treatment of acute benzodiazepine toxicity in a clinical setting: the role of antidotes
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - August 1, 2022 Category: Drugs & Pharmacology Authors: Nasim Zamani Hossein Hassanian-Moghaddam Naghmeh Zamani Source Type: research

Evaluating the pharmacokinetics of extended release viloxazine in the treatment of children with attention-deficit/hyperactivity disorder
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - July 26, 2022 Category: Drugs & Pharmacology Authors: Ann Childress Shelby Burton Source Type: research